GVS S.p.A.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

GVS S.p.A. - overview

Established

1979

Location

Bologna, -, Italy

Primary Industry

Industrial Machinery

About

GVS S. p. A. is a leading provider of advanced filtration solutions, specializing in high-performance filters and systems for the MedTech, Life Sciences, and industrial sectors, aiming to enhance safety and efficiency across various applications.


Founded in 1979 in Bologna, Italy, GVS S. p. A. focuses on developing filtration technologies.


The company has undergone strategic developments to expand its product range and market reach. The current CEOs are Massimo Scagliarini, Matteo Viola, and Mattia Ravizza. GVS Filter Technology specializes in providing advanced filtration solutions across multiple sectors, including MedTech, Transfusion Medicine, Life Sciences, Safety, and Energy & Mobility. Their core product offerings include high-performance filters and filtration systems designed to address critical applications such as blood filtration, bioprocessing, and air quality management.


These products are engineered to ensure safety, enhance performance, and meet regulatory standards within healthcare, industrial, and environmental markets. GVS serves a wide array of clients, including hospitals, pharmaceutical companies, laboratories, and manufacturers in regions such as Europe, North America, and Asia-Pacific, thereby addressing their needs for reliable and efficient filtration technologies. In 2023, GVS Filter Technology reported a revenue of USD 459. 73 mn and an EBITDA of USD 99.


75 mn. The company's revenue structure primarily revolves around B2B transactions, where they partner with healthcare institutions, pharmaceutical companies, and industrial manufacturers. The company engages in direct sales of its filtration products, tailored to meet specific client needs and compliance requirements. Clients typically place bulk orders or long-term supply agreements for flagship products, which include specialized filters for blood collection and processing, as well as industrial air filtration systems.


Pricing strategies are designed to reflect the quality and application of the products, ensuring clients receive value consistent with their operational demands, although specific pricing details are proprietary. The structure of these transactions reinforces GVS’s commitment to providing tailored solutions while maintaining robust relationships with key stakeholders in their market sectors. GVS S. p.


A. is strategically positioned to launch new products aimed at enhancing its filtration solutions portfolio. The company is also exploring expansion into new markets, including Asia-Pacific and North America, with plans to establish a stronger presence by 2025. The most recent funding transaction occurred in December 2014 when Mindful Capital Partners exited their stake in GVS S.


p. A. , although specific details of how the funding was utilized are not disclosed.


Primary Industry

Industrial Machinery

Sub Industries

Industrial Machinery

Website

www.gvs.com

Verticals

Manufacturing

Total Amount Raised

Subscriber access only

GVS S.p.A. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Trade SaleCompletedKuss Filtration Inc.-
Unspecified ExitCompletedGVS S.p.A.-
GrowthCompletedGVS S.p.A.-

Displaying 1 - 3 of 3

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.